Dana-Farber Cancer Institute: Scientists identify factors for predicting which patients with ovarian cancer won't benefit from immunotherapy-PARP inhibitor combination

Press/media: !!Press / Media

Period19 mar 2020

Mediabevakning

1

Mediabevakning

  • TitelDana-Farber Cancer Institute: Scientists identify factors for predicting which patients with ovarian cancer won't benefit from immunotherapy-PARP inhibitor combination
    Medianamn/-företagIndia Pharma News
    LandIndien
    Datum19/03/2020
    PersonerSampsa Hautaniemi